CJC-1295 (No DAC) + Ipamorelin Blend — GHRH + GHRP Research Peptide
The CJC-1295 (No DAC) + Ipamorelin blend pairs a modified 30-amino-acid GHRH analog with Ipamorelin, a selective pentapeptide GHSR ligand — one of the most widely referenced GHRH + GHRP pairings in research literature.
- 5 MG vial: CJC-1295 5 mg + Ipamorelin 5 mg (10 mg total)
- 10 MG vial: CJC-1295 10 mg + Ipamorelin 10 mg (20 mg total)
- Purity: ≥99% HPLC, third-party tested, COA included
- Shipping: USA same-day (before 2pm CT M-F) · free over $200
Related: Ipamorelin alone · Tesamorelin + Ipamorelin · Sermorelin
For laboratory research use only. Not for human or animal consumption. Full details ↓
$ 85.00 – $ 115.00Price range: $ 85.00 through $ 115.00
| Quantity | Price | Discount |
|---|---|---|
| 3-5 | $ 76.50 | 10% |
| 6-9 | $ 72.25 | 15% |
| 10+ | $ 68.00 | 20% |
Add $ 200.00 to cart and get free shipping!
Description
CJC-1295 (no DAC) + Ipamorelin is a lab-grade GHRH + GHRP research peptide blend supplied for laboratory research and in-vitro studies. It pairs a modified 30-amino-acid GHRH analog (CJC-1295 without the drug affinity complex) with Ipamorelin, a selective pentapeptide ghrelin-receptor (GHSR) ligand — one of the most widely referenced GHRH + GHRP pairings in research literature.
What is in this blend
| Vial size | CJC-1295 (no DAC) | Ipamorelin | Total |
| 5 MG | 5 mg | 5 mg | 10 mg |
| 10 MG | 10 mg | 10 mg | 20 mg |
Why the two are studied together: CJC-1295 is characterised in the literature as a GHRH-receptor analog, while Ipamorelin acts at a separate receptor (GHSR). Because the two act on different receptor pathways, the combination is frequently examined in pulsatile GH-release research and in comparative receptor-pathway studies against either compound alone.
The “no DAC” distinction: The DAC (drug affinity complex) modification extends the half-life of CJC-1295 considerably. The no-DAC variant, with a reported half-life of around 30 minutes, is studied where a shorter-acting profile is required for the experimental design.
Research-grade specifications
- Components: CJC-1295 No DAC (GHRH analog) + Ipamorelin (GHSR ligand)
- CJC-1295 length: 30 amino acids
- Half-life: ~30 minutes for the No DAC variant, reported in published literature
- Available sizes: 5 MG, 10 MG
- Format: Lyophilized powder, single-vial blend
- Purity: ≥99% HPLC, third-party tested
- Documentation: Batch-specific Certificate of Analysis included
Storage & handling
- Store lyophilized vials refrigerated at 2–8°C, protected from light and heat
- Reconstitute with bacteriostatic water; reconstituted material has a shorter storage window
- Follow your laboratory’s standard peptide handling protocol
Product content and references are provided for educational and experimental research purposes only. This product is not a pharmaceutical and must not be used in humans or animals. Purchasers are responsible for compliance with all applicable local, state, and federal regulations.
CJC-1295 research reference: View study on PubMed
Ipamorelin research reference: View study on PubMed
Buy CJC-1295 + Ipamorelin Blend — cGMP Manufactured in Dallas, TX
LiveWell Peptides manufactures the CJC-1295 (no DAC) + Ipamorelin research blend in our cGMP facility in Dallas, Texas. Every vial is third-party tested by independent laboratories to verify ≥99% HPLC purity, amino acid identity by mass spectrometry, and endotoxin limits by LAL testing, and ships with a batch-specific certificate of analysis published on our COA page.
Supplied as lyophilized powder for reconstitution. US orders placed before 2pm CT (Mon–Fri) ship same-day in cold-chain packaging, with free domestic shipping on orders over $200. International shipping is available. Sold strictly for research use only — not for human consumption.
Why Researchers Source the CJC-1295 + Ipamorelin Blend from LiveWell
LiveWell Peptides is a US-based cGMP peptide manufacturer headquartered in Dallas, Texas, supplying research-grade peptides and peptide blends to laboratories, universities and qualified independent researchers across the United States and internationally.
Documentation, not claims
Every batch of this blend ships with a verified certificate of analysis (COA) confirming identity and purity. COAs are published on our COA page rather than supplied only on request, because purity should be documented, not asserted.
Four-point analytical testing
Each lot is analysed by HPLC for purity, mass spectrometry for amino acid identity, and LAL testing for endotoxins, with independent third-party verification on top of in-house quality control.
Why a blend rather than two vials
Combining both compounds in a single documented lot reduces preparation steps and variability between components in a research setting. Which approach suits a study depends on the research design — single-compound vials are also available individually.
US manufacturing and cold-chain logistics
Peptide stability depends on temperature control. Orders ship same-day from our Dallas, Texas facility in thermo-insulated packaging, with free domestic shipping over $200 and international shipping to Colombia, Mexico, Brazil, Argentina, Chile and Peru.
Bulk pricing and private label
Volume pricing applies automatically at checkout — 10% off at 3–5 units, 15% at 6–8, and 20% at 10 or more. For wholesale quantities or private label enquiries, contact our sales team.
Disclaimer: This product is sold strictly for laboratory and research use only. Not for human consumption. No medical claims are made or implied. Researchers are responsible for compliance with all applicable local, state, and federal regulations.
Related research compounds
Ipamorelin alone · Sermorelin (GHRH analog) · Tesamorelin + Ipamorelin Blend · IGF-1 LR3 · All peptide blends · Certificates of Analysis
Research literature
CJC-1295 has been the subject of 28 peer-reviewed publications indexed in PubMed. Selected recent literature for research reference:
- Mendias CL et al. (2026). Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. PMID: 41966639
- Coutinho LFD et al. (2026). A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. J Sports Med Phys Fitness. PMID: 41880199
- Uçaktürk E et al. (2026). Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry. J Pharm Biomed Anal. PMID: 41138283
- Rahman OF et al. (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. PMID: 41490200
- Mayfield CK et al. (2026). Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. Am J Sports Med. PMID: 41476424
References are provided for research reference only. Inclusion of literature does not constitute a recommendation, endorsement, or claim for any specific use of LiveWell Peptides products. Products are sold for laboratory and research use only and are not intended for human consumption, injection, topical application, or any other administration to the human body.
Frequently Asked Questions
What is in the CJC-1295 + Ipamorelin blend?
Each vial contains equal amounts of both compounds — the 5 MG vial has 5 mg CJC-1295 (no DAC) + 5 mg Ipamorelin (10 mg total), and the 10 MG vial has 10 mg of each (20 mg total).
What does “no DAC” mean?
DAC stands for drug affinity complex — a modification that extends CJC-1295’s half-life considerably. The no-DAC variant has a reported half-life of around 30 minutes, making it the choice where a shorter-acting profile suits the experimental design.
Why are CJC-1295 and Ipamorelin studied together?
CJC-1295 acts at the GHRH receptor while Ipamorelin acts at the ghrelin receptor (GHSR). Because the two engage different receptor pathways, the combination is examined in pulsatile GH-release research and in comparative studies against either compound alone.
How does this differ from the Tesamorelin + Ipamorelin blend?
You may also like
